Breast Cancer — Trials, FDA Actions & Pivotal Research
78 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Breast Cancer.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Breast Cancer trials
Recruiting trials by city
Cities where Breast Cancer trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Results postedBreast Cancer: Financial Reimbursement Study Shows High Feasibility· May 18, 2026
- Results postedBreast Cancer: Lower Acute Toxicity with 10-Fraction Radiation Therapy· May 7, 2026
- Results postedNovel Cone-Beam CT Demonstrates Superior Image Quality for Radiotherapy· May 6, 2026
- Results postedPenguin Cold Caps Trial Posts Results for Breast Cancer Hair Loss· Apr 28, 2026
- Results postedMetformin Hydrochloride & Doxycycline Trial for Breast/Uterine Cancer Terminated· Apr 22, 2026· drug: Canagliflozin
- Results postedBreast Cancer: Real-world Palbociclib Treatment Patterns in Japan Posted· Apr 21, 2026
- Results postedBreast Cancer: RSI Screening Identified Zero Cancers in Completed Trial· Apr 17, 2026
- Results postedBreast Cancer Lifestyle Intervention Trial Posts Feasibility Results· Apr 16, 2026
- Results postedBreast Cancer Survivors: EHR Tool Boosts CV Health Discussions· Apr 15, 2026
- Results postedPembrolizumab Combination Trial for Solid Tumors Reports DLTs at High Dose· Mar 27, 2026· drug: Pembrolizumab
- Results postedBreast Cancer MRI Screening Trial Terminated, Posts Initial True Positive Data· Mar 20, 2026
- Results postedBreast Cancer: Single-Fraction Radiotherapy Shows Good Cosmesis Rates· Mar 17, 2026
- Primary completionBreast Cancer: Digital Self-management Tool Trial Reaches Primary Completion· Mar 15, 2026
- Results postedTrastuzumab Deruxtecan Trial for HER2+ MBC Terminated with Limited Data· Mar 12, 2026· drug: Trastuzumab Deruxtecan
- Results postedBreathwork App for Breast Cancer Survivors Shows Improved Symptom Management· Mar 11, 2026
- Primary completionBreast Cancer Analgesia Block Trial Reaches Primary Completion· Mar 3, 2026
- Results postedPembrolizumab + HER2 BATs Trial for Metastatic Breast Cancer Shows Low DLTs· Feb 27, 2026· drug: Pembrolizumab
- Results postedBreast Cancer: Culturally Aware AET Intervention Feasibility Results Posted· Feb 24, 2026
- Results postedPembrolizumab with HIFU for Metastatic Breast Cancer: Greater CD8+ TILs Change…· Feb 9, 2026· drug: Pembrolizumab
- Results postedPembrolizumab/NT-I7 Combination Shows Dose-Dependent TEAEs in Solid Tumors· Feb 9, 2026· drug: Pembrolizumab
- Results postedBreast Cancer: Molecular Breast Imaging and Tomosynthesis Detection Rates Posted· Feb 3, 2026
- Primary completionDapagliflozin Trial for Breast Cancer Cardiotoxicity Reaches Primary Completion· Jan 30, 2026· drug: Dapagliflozin
- Results postedPembrolizumab Trial in TNBC Terminated, 1 of 8 Patients Achieves pCR· Jan 23, 2026· drug: Pembrolizumab
- Results postedKeytruda/TAK-500 Solid Tumor Study Terminated, Adverse Event Data Posted· Jan 22, 2026· drug: Pembrolizumab
- Results postedBreast Cancer: IMRT Trial Results Posted for Implant Reconstruction· Jan 20, 2026
- Results postedKanSurvive-ECHO: Mixed Results for Cancer Survivorship Care Metrics· Jan 14, 2026
- Results postedBreast Cancer: Evening Endocrine Therapy Shows Greater Toxicity Reduction· Jan 8, 2026
- Results postedNew Cone-beam CT Scanner for Radiotherapy: Image Quality Results Posted· Jan 6, 2026
- Primary completionTrastuzumab Deruxtecan Phase 3 Metastatic Breast Cancer Trial Withdrawn· Jan 1, 2026· drug: Trastuzumab Deruxtecan
2025
- Primary completionBreast Cancer Trial Completes Primary Data Collection for Radiation Dose Study· Dec 31, 2025
- Primary completionBreast Cancer: Locoregional Treatment Trial Withdrawn at Primary Completion· Dec 31, 2025
- Primary completionBreast Cancer: Hypofractionated RT Trial Reaches Primary Completion· Dec 31, 2025
- Results postedPembrolizumab Plus Carboplatin Trial Results for Breast Cancer Chest Wall…· Dec 22, 2025· drug: Pembrolizumab
- Results postedBreast Cancer: dcl-hNAC Grafts Show Complete Healing in Reconstruction· Dec 17, 2025
- Results postedBreast Cancer: IORT Boost Trial Results Show 10 Local Recurrences· Dec 12, 2025
- Results postedHOPE-Genomics Trial Results Posted for Cancer Patient Education· Dec 11, 2025
- Results postedBreast Cancer: Telemedicine Study Reports Stable Quality of Life Scores· Dec 10, 2025
- Results postedBreast Cancer: mHealth Pain Coping Skills Training Results Posted· Dec 9, 2025
- Results postedPembrolizumab, IRX-2, Chemo Combo Shows Higher pCR in TNBC Trial· Dec 2, 2025· drug: Pembrolizumab
- Primary completionBreast Cancer: ULTIMO Trial Completes Primary Phase for Radiation Study· Nov 28, 2025
- Results postedBreast Cancer: Microwave Imaging System Shows 90.32% Lesion Detectability· Nov 26, 2025
- Results postedPembrolizumab/Lenvatinib Combo Shows Up to 77.4% DCR in Ovarian Cancer· Nov 17, 2025· drug: Pembrolizumab
- Results postedAtezolizumab Triplets Show Improved Response, PFS in HR+/HER2- Breast Cancer· Nov 10, 2025· drug: Atezolizumab
- Results postedTargeted Intra-Operative Radiotherapy Trial for Breast Cancer Terminated· Nov 6, 2025
- Primary completionBreast Cancer: Internal Mammary Nodal Irradiation Phase 3 Completes· Nov 1, 2025
- Results postedBreast Cancer Screening: Trial Posts Behavioral Response Data· Oct 24, 2025
- Results postedBreast Cancer: Axillary Lymph Node Excision Reduces Recurrence Risk· Oct 20, 2025
- Results postedBreast Cancer: Trial Results Posted for Nipple Discharge MRI Study· Oct 15, 2025
- Results postedBreast Cancer: PRISM Intervention Improves Resilience and Growth· Oct 14, 2025
- Results postedBreast Cancer: Retrospective Study on Neratinib Patient Profiles Posted· Oct 6, 2025
- Results postedBreast Cancer: US-RF + Endocrine Therapy Trial Reports Recurrence Data· Oct 1, 2025
- Results postedBreast Cancer: No Significant Difference in NT-proBNP Levels During Anesthesia· Oct 1, 2025
- Results postedBreast Cancer: Patients Spend 404 Minutes/Week on Care Tasks· Sep 16, 2025
- Primary completionAtezolizumab Trial for HR+ HER2- Breast Cancer Completes Phase 3 Study· Sep 12, 2025· drug: Atezolizumab
- Results postedBreast Cancer: Enhanced Density Notification Improves Knowledge in Latinas· Aug 28, 2025
- Results postedBreast Cancer: Intervention Boosts Risk Assessment and Screening Uptake· Aug 28, 2025
- Results postedAtezolizumab Combination Trial Reports 15.57-Month DOR in Metastatic Breast…· Aug 8, 2025· drug: Atezolizumab
- Results postedMyoStrain® Trial Results Posted: Detecting Cardiotoxicity in Breast Cancer· Jul 29, 2025
- Results postedBreast Cancer: Trial Results Posted for Multigene Assay Study· Jul 29, 2025
- Results postedBreast Cancer: Cryotherapy Trial Posts Neuropathy Prevention Incidence Data· Jul 28, 2025
- Primary completionBreast Cancer: Accelerated Radiation Therapy Trial Reaches Primary Completion· Jul 15, 2025
- Results postedBreast Cancer: Cardiac Monitoring Schedules Show No Significant LVEF Difference· Jul 14, 2025
- Results postedLighting Intervention Trial Results Posted for Cancer-Related Fatigue· Jul 9, 2025
- Results postedBreast Cancer: Time Restricted Eating Trial Results Posted· Jul 4, 2025
- Results postedCancer Patients' Treatment Priorities Posted for Elderly and Young· Jul 1, 2025
- Results postedBreast Cancer: Exercising Together Trial Posts Dyadic Coping Results· Jul 1, 2025
- Results postedSymptom Management for Young Adult Cancer Survivors Trial Results Posted· Jun 29, 2025
- Results postedMindful After Cancer Intervention Shows Feasibility and Acceptability· Jun 25, 2025
- Results postedTrastuzumab Deruxtecan Phase 2 Results Posted for HER2+ Breast Cancer with…· Jun 24, 2025· drug: Trastuzumab Deruxtecan
- Results postedBreast Cancer: IMRT Trial Reports No Acute or Late Radiation Toxicities· Jun 13, 2025
- Results postedBreast Cancer: Bright Light Trial Results Posted for Symptom Management· Jun 10, 2025
- Results postedSelf-Administered Hypnosis Reduces Hot Flash Scores in Breast Cancer· Jun 5, 2025
- Results postedPembrolizumab + Paclitaxel Trial Posts 8.1-Month PFS in Post-CDK4/6 HR+/HER2-…· Jun 3, 2025· drug: Pembrolizumab
- Results postedPembrolizumab-Based Therapy Shows 100% 2-Year DFS in TNBC Subgroup· May 31, 2025· drug: Pembrolizumab
- Results postedPembrolizumab Combo Improves PFS, OS in HR+/HER2- Metastatic Breast Cancer· May 30, 2025· drug: Pembrolizumab
- Results postedPembrolizumab + Olaparib Combination Shows Overall Response in Breast Cancer· May 29, 2025· drug: Pembrolizumab
- Results postedBreast Cancer: Tailored Counseling Boosts Genetic Risk Assessment Uptake· May 28, 2025
- Results postedInvestigational Curved Paddle Improves Breast Cancer Screening Comfort· May 21, 2025